Non-surgical treatment of benign paroxysmal positional vertigo (BPPV) - a randomised controlled trial of procedures and practices

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN84087880

Enrollment

100

Registered

2003-09-12

Start date

2002-02-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Signs and Symptoms: Benign paroxysmal positional vertigo (BPPV) Signs and Symptoms Benign paroxysmal positional vertigo (BPPV)

Interventions

1. Particle repositioning manoeuvre alone 2. Particle repositioning manoeuvre plus soft collar & sleeping instructions 3. Particle repositioning manoeuvre with bone vibrator 4. Particle repositioning

Eligibility

Inclusion criteria

Inclusion criteria: Outpatients who have a positive Dix-Hallpike's positional test diagnostic of BPPV Five groups, approx 20 patients per group. 5 Patients recruited 2001- 2002.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Secondary

Measure	Time frame
Not provided at time of registration	—

Primary

Measure	Time frame
All the above described methods are recognized standard treatment procedures for BPPV in current clinical practice. Patients will be reviewed in the clinic 8 weeks post-treatment, when they will be required to answer the Dizziness Handicap Inventory (DHI). Questionnaire. A negative Hallpike's test during this visit would be considered as a positive outcome.	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026